Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Staphylococcus haemolyticus JCSC1435, JCSC1435

>SH0086 
MPIFNKINASKDIDSFLNDLSKNLKFRNNLHTSKELDDTPEIIFYEDDDN
DIFAIGEIKSFELSEDSGISFNFDKKIHFFKLEEEDYKSLIINKNNIAFI
TTALIQKIEDKILKDTENIIELETDKKTENDELERKFLKHFMNKLSNENL
VYSPKDILNFHTAMKTSKLVILSGMSGTGKSKLIKAYANSLGLKDNFKFI
PVSPSWSEDSDIIGYADTLNMIYRPDDHGLIETLIQAKLNPDKLFIICFD
EMNLARIEHYFSQFLSLLESDVENRKLQLYNKELGGKLYNSSKYNHEITI
GKNVRFVGTVNIDESTYHFSNKVLDRADLITLEVMPFKQLVEITNIEKIK
TTEGISFEQEYIKSFFKNSKTIDLDNDTIDFLQEMHNTLLNINNQSGIGP
RVIKHIDYYLKNIPNYEGILSYGEGLDFQVIQRILSKIRGSREELELLIG
SYNPNNNSVTSSNLLALMDKYKNISDFTNSKKVILNKSKELYLNGFTF
>SH0081 
MESLNEGYAKIFDTDMPNRKLLNDIGYMGQSDALYESLSARENLVFFGNL
MGLKGKELKQAIKDNMKLVNLDNELDKTVSNFSGGMKRRLSLAITLLSNP
NLIILDEPTVGIDPSLRKEIWKQLRELTSEDKSVIVTTHVMDEAERCDYV
GLIVNGKLFTIGTPHELKEKFKVDSIEEVFIKAEKEVKS
>SH2613 
MAQTIAKLTDAVKQYDKHKVLDHISLNIQEGELIGLIGPSGSGKTTTIKC
LLGMEKLNSGTTEIFEQRMPNRQVLSHIGYMGQSDALYESLSAKENLIFF
GHLAGIKGKQLISSINHNMGLVNLEEKLNKTVNTFSGGMKRRLSLAITLL
SDPSLIILDEPTVGIDPKLRQQIWNQLKYLTKQGKAVIVTTHVMDEAERC
DKIGLIVEGRLFAIGTPNELKQKFNVETIEEVFIKGEEVKNQ
>SH0699 
MALQLKHITKTFGNGDAQTEVLKNINFSVNQGEFIILSGASGSGKSTLLN
ILGGLLSPSSGDVLYKGENLFSKEVDKTSLRLNDIGFIFQSSHLVPYLTV
REQLMIVAKEAGIKRKEAKDKAQRLLNEIGLSHRLDVYPHLLSGGEKQRV
AIMRAFMNEPKIILADEPTASLDADRATSVVQMIKAHVQTKNMIGIMITH
DKRLFEYADRVIEIQDGKIEL
>SH0407 
MTIHMLWKMIAQNFKMQRHVIMPFILALSIMFATEFILLSLNMNDYVQKR
SQLLPIFIGVGNFFMSVLGFIFILYANRFMMKRRQQELAMNMILGMEKKH
FRMIMLIEMVYQYVLIALISITGGYLFGVLIFMLMNKLMHQTGMSLLDYP
FNVKAMCITLIILAAVMLFLFLINNLKILFQSPIKLIHQRQRAERKLPKF
VLYALLVIGIVTLFSSYHIALSNQMVLRSLYDLFGAIGLVMIGTYCLYLS
LGVLLLDWLKRIPKMYYNPKYFFTISGLQSRMNSNAIGLASITMLCTFLI
VTVGMTISTYRGISDQVDSIMSDQYRVSIDGNLHNNKKTQEKVRRLERDI
KDHAKVDFFKKNAVSLIAVDYKQPGLFKHRNNKDYNMTINSAYLVIMTQH
DYNELNTKKVKLKHEELGFESLNQPFKKLSKATMMGNQFNIKQLNGHNYS
YPVPGALTVVTPDDKTFQQLTNYYVNADKNDRHGTQKVQNTFMHFNIMTK
HTTDFDKVKNQLIQRYKVNIDDKKEVAGTLYEINGGLIFIGTVVSIILFI
GTFLMMYYKNVAEGYEDRKNYQIMQHVGIDNDRIKDTINKQIIWIFALPI
IVATIHVIFASKIIFNVLGILNVNHVGVFVTSYVGVIISVVVIYALMYWV
TSRIYYMIVNRYH
>SH0162 
MLKFDEVTKEFQDGNHTIEAVKPTSLSFEKGELIAIVGPSGSGKSTFLTM
AGALQTPTSGEIYINDKKISKMSQKQLAKMRMKEIGFILQATNLVPFLTI
KQQFHLLKSYKKDVLSTEEYDKLLSDLGLKEIENKLPSEVSGGQKQRVAI
AKAIYTQPSIILADEPTASLDTENAMAVMEILKEQSKQRHKTCIIVTHDE
RLTKFCDKVFHMEDGRLKEK
>SH1125 
MTVKVEHLTGGYGKRPVIEDINFELKAGEIVGLIGLNGAGKSTTIKHMLG
LLTPTEGNLSISNTEITDDIEVYRKKLSYIPESPIIYEELTLEEHIAMTA
MAYQLSKEEAMKRARPLLKTFRLENELKVFPSHFSKGMKQKVMIICAFIV
NPELYIIDEPFLGLDPLGIQSMLDLMVEKKNEGRTVLMSTHILATAERYC
DRFIILDKGKVVAFGDLEELRKQTGLSGHTLDDIYIHVTQGGQENG
>SH1024 
MKLENITKTYGDNNVLDNINFDFGNSKIVGLIGKNGVGKTTLMKVMNGNI
INFKGKVQLNDNENVGYLIEHPKLYDNKTGLNNLKLFAQVLGKGFDKEYT
DKIIDAFGMRPYIKKKVKKYSMGMKQKLAIAVSLMNKPKYLILDEPTNGM
DPDGSIDVLETIQSLVNDLEMKILISSHKLEDIELICDRAVFLRDGNFVQ
DVNMKDGSAQDHTSIKFEVSEFNTALDYLTEHFNVLQSHKDSGEIMIKAQ
KDYKQLLKSLAQKDLYPKYIETRKSSLRDTYFNINQRGDK
>SH0705 
MKKMVLINIITIVVLVVVGIVGFYLYHNATSFVTTDNAKVDGEQIQISSP
TSGQIKSLDVKQGDKVKKGDKVAEVSGQSQSGESQTMDIKMPQNGTIVKT
SGMEGSVAQAGSPIAYAYNLDDLYITANIDEKDVSSVEKGDKVDVTIDGE
DSDVDGKVEEVGQATAASFSLMPSSNTDGNYTKVSQVVPVKISLDSAPSK
NVVPGMNAEVKIHKD
>SH1022 
MNVIEVKDVSFQSSAFSINNLSFSIPQGFVTGFIGANGAGKTTIIRMIMD
IIEPKQGHISIFGEKIANKPKWIKNKIGFVYSEVYFNQQWTAKKLEKMVS
PFYTDWDSQAFKNYLEKFNLPFDEKIKHFSTGMKMKLSLALALSHHAELF
ILDEPTAGLDPIVRNEVLEILQSELLDEHKTLFISTHIISDLEKIADYLV
HIKDGEVIMQGFRHQLQEQYSIVQGDNQDLDEELNRLFLYKEVKSTGFVG
FTKQAQVFKELFGKKVNIKQPTIEELMIYIEKSKSNDNQIDFQQSRLIK
>SH2576 
MAFLLLHNYTDFIEYIYLYLLKQNQKSKNSDHRTANIINNLVFYYKKTNK
NKNVIRKYTNYSTYLSVAQGIHSAAFLYSGKENIIDRLFIYFNYHLEYYE
NMLFIDNVSRSLFKNLFYEDVNSFEDTDKNFCDDICELLFAQIYNNKNIT
>SH0406 
MLLDVKNVKKTFGRGLNATTALNGISFTVDKGEFVAIMGESGSGKSTLLN
LIATFDKVSEGNITINNQDIRKLRNKQIAHFRRDNLGFVFQDFNVLPTMT
NRDNILMPLVLANRSHKVMEQRMNTLSSKLGIEKLLSKYPYQVSGGEQQR
IAIGRALINEPDLLLADEPTGALDSKTSKQIMTLFREINDNTQTILMVTH
STIDASYAKRVLFIKDGRLYHEIYRGEESQQDFQKRIADSLAILNESGD
>SH2614 
MKLLAMIQRVIIELLKDKRTLALMFLAPLLVLTLMYFIFNSDEDTTLTIG
IDNSVSTQITDSIESNNVKFKDFTSSQHIKSKIEHHHLDAFIYQNNQTIH
VTYTNEDPSKSASIKQLLHQSIQKNKMNDIKKVMVSLPQSAKNKDTKDIQ
LDNTYLYGDEDSNYFDKMFPILMSFFVFLFVFLISGIALLRERTTGTIER
VLATPIKRSEIVFGYLIGYGIFAIIQTLIIVLFSIYLLNINLAGSLAYVI
LINILLAIAALVMGIFISTFANSEFQMIQFIPIVAIPQVFFSGIFPLENM
SPWLSNIGYLFPLRYAGHALTNIMIKGQGWSNIWFDVLILFVFIIVFTTM
NIIGLKRYRKV
>SH0082 
MRFNAIFVRVTKELLRDKRTLALMLLAPVLVLTLMYFIFNTNNDVNLKVG
VDENVPNKIVDALPSDKVKIKEYDSPSSIKKTIVNSDLDVYIEKKGDKLD
VTYKNEDPSNTGTTKQLLGSAIQKNKLQDMAKVINKIPSNLKQGNSAQGE
QITLDNHYLYGDADSTYFDKMFPILIGFFVFFFVFLISGIALLRERTKGT
LERLLATAVKRSEIVFGYLAGYGMFAVLQTLIIVFYAIYLLKIEVAGSIW
WVLLVNILIALSALAIGIFVSTFANSEFQMVQFIPLVVIPQVFFSGIIPL
DSVADWVSSIGYIFPLRYAGDALTNIMIKGEGFNYIWFDITILLVFIIGF
TILNIVGLKRYRKV
>SH0677 
MGLIIAVITLPFTDQIASILCASGETLNYTSDYLKIEFLSTPFVILFFVL
EQFARAIGKPIISMIGMLSSVGINIILDPILIFGLHLDVVGAALGTAISN
AIAGLFFIIYFSRKNETLSFNVKHAKPTKAMMQEIFKIGIPAFLMVVLMG
VTGLVVNLFLATYGNYAIASYGISFRLVQFPELIIMGLSEGVVPLIAYNF
VSNKTRMKDTIKVVIVSIAVIFAVCMTVVLVAGHSIVQLFSTDPQIVVLA
TFILKVTMTSLLLNGIGFLFTGMLQATGQGRGATIMAIAQGTVIIPVLFV
LNSLFGLTGVIWSLLIAETVCAFLAMFIVYSLRNRLTVDKASLIEVE
>SH0118 type I restriction enzyme restriction chain
MAYQSEYALENEVLQQLESLGYERVNIHNVEQLHDNFRSIINECHKDKLN
EKPLTDREFERLMTRINGKSVFDSAMQLCNSYVLKRDDDTDLYIDFMNLK
QWCQNKFQVTNQISVKDKYKSRYDVTIPGKKLGSVAK
>SH0676 
MKDEQLFYFEESSIFKAMMHFSLPMMIGSLLSVIYGILNIYFIGFLDNSH
MISAISLTLPIFAVLMAFGNLFGVGGGTYISRLLGAKDYIKSHYVSSFSI
>SH0135 
MHTFSVEGKNISKEINHQAIIKNMSMNFPNNSIILIEGKNGSGKSVTLKM
LANIMKPSSGLMSVKGNISYAPDHLPMTINLTVKEYLDFIDSISIKNQSD
IKISQLTHLFNLEPFLQKRIYECSKGTQQKVNLIQCLIKKADIYIMDEPF
SGLDKNAIAELKSLLIQFKQFATIVLTSHEQIVDFTFVTHRYNIEQNHLI
DNSSTNADMKMLIKIIQVSEKELSIILKEHDFQMSKDGSIIVNSSQSNQV
IALLIHNGYFIEEVRRYTKNGVN
>SH0620 
MKKTFLFSGVVLVIILFICSIMIKWQPNYSMISPTSQNYLDSIVKNEMND
GHIPGVSVLIIKDNKMLLNKGYGYANIKNKQKVTSNTRFEIASNSKAMTG
YAIMQLVNERKIKLNDPISKYIPNFHMKYKGKKVEITINQLITQTSGIPG
DITDNDKITKKTDSLDGIVNSINGRSLNHRPGEQFEYANMNYDILGLIVQ
NISHSPYSSYMSEHIFKPLNMKHISTKESNKKGGDDAQGYDIQHNKAYSD
NPKFNIGDNPAAYLMASTHDLEPWIKFQLHPPKHLKSLVETTHKPKVKTN
DDDDSQYATGWFVTKDNQETLIYHPGTLENYSSYIILNPKKDYGIVVLGN
AYSSHTPTLAKHLNTQLSQGQHIDTVQYYINQYQTMIIVVTIVIWIMVAI
TLIYLYRHMTSHQSILLSFQRKNTKYRILILSIGFILILGLLHLLPSLLL
NGSDWQFIMTWLPAPAKVTILGFITLLTSLFGLVLLKIITNTNK
>SH0791 
MIKKMLTFSLGNKFAIFLMVVLVILGGVYSSAKLKLELLPDAENPVISVQ
TTMPGATPQTTQDEISSKIDNQVRSLAYVKSVETQSIQNASIVTVEYNNG
TDMDKAEEVLKKEIDKLDFKDGVSEPELTRNSMDAFPIVAYSFTNKNDDL
KTTTKEINDQLIPKLQTVDGVQNAQLNGQTTRQVTLKFKQNKLDEAGLTA
DDVENYIKTATRETPLGLFQFGKNEKSLVVDGQFKSVKALKDLEIPLTIS
GQSQSGSSDDQSGSEMSSTGDNASSSSSQSQMSNQSQASNGEMPSVPLSE
LATITVGDERESISKTNGKDAVNVQIMKAQDANTVQVAKEAQNKIDEFVK
NNDDIKATKTMDTAKPIEDSLYTMVEKAALGTIVAIIVILLFLRNIRTTA
ISIVSIPLSILIALIALKLSDVSLNILTLGALTIAISRVIDDSIVVVENI
YRRLSDPKEELSGNNLVISATREVFKPILSSTIVTIIVFLPLAFVSGSVG
EMFRPFALAIAFSLLASLLVSITVVPALASTFFKKGIKLKRNSQRQNDRG
LGVVSKSYRKILNWSLNHKWIVLVISVVILVGSIALGGAKLGTSYISTGD
DKFLAVTYTPKPGETEKSVLDHAKQAQKYLQSKDKVKTVQYSVGGPSPAD
PTGSTNSMAIMLEYDKDTPNFEEEPDKVISHLSKMNQPGEWKNQDMGNGS
GNDSVEVTVKGPSTNAIKDTVAKVEQKMKSVNGITNVKSDLSQTYDQYEI
KVDQNKATEKGISAGQLALNLNENLPEKTITTVKENDNKVDVKVKQNKQT
YWSRNKLNNMELKSPTGETVKLKDIAELERTTTPSKLVQEDGDYATTVSG
KITDSDVGGVSSKVMNKINNIDKPDNVKVNVGGATDDINQAMTQLAFAML
VAIVIVYLVLVITFKGGLAPFTILFSLPFTIIGVVLALLITGETISVPSL
IGMLMLIGIVVTNAIVLIDRVITNEHEGMSMKEALLEAGGTRIRPILMTA
IATIGALLPLLFGQDSSILISKGMAATVIGGLISSTLLTLIVVPVIYEIL
FTLKGKLTRK
>SH2304 ABC-type multidrug transport system, ATPase component
MDVLTVEHLTKKIGNKTILKDISLNLKRGQIVGLVGANGAGKTSLMKVIL
GYSIYQEGNFEVIENKHKKSNVGALIENPGIYPFMSGYDNLKLLNETKNT
QDIDTIVSQLKMDEYIHNKAKTYSLGMKQKLGIAIAFLNQPQLIILDEPM
NGLDPRAVRDVRELIVKKAEEGITFLISSHILSELVKITNSILIINKGKI
VTETTEEELNQYKDNDLENVLLSIIDKEDQS
>SH0698 
MNLAWKEIKFYRFRYTLIMLIIFLLGSMVLFISGLAQGLARENISYLNNM
PAEHYIVEDNKEPKLESSQLNQSQQNKIEKIIHENATQMGTQTLKINQQD
QDVITLNTPKHLTPKLVSGNYPKKQNEIAISEKLTGNDLKVGDTVTFKGH
HHNYKISGIMNESMYSHSSMILMNKEAFKSLNKQVSTFYPVDKINKDNKE
SLKQIKGIKVVNEKALTDNIASYQAEQMPLNLMIISLFVITAIVLSAFFY
VMTIQKIPQIGILKAIGIKTKHLLTALLLQIILTTMVGVILAFSVILILN
AFMPVTMPFYLSYSQVLLMIVVFLIVGLIGALLSFIKVLKVDPIEAIGGM
E
>SH1777 
MSKAYADYIEQRTKNKGFYSNARWRKTRLKVLARDHYECVMCNAEGRLTI
NQKQSLEIDHIIELEKQPELAYDLNNLRTLCKYHHNKRHGRFEHNPNNRK
NKFNDENW
>SH1589 
MIYINQLKKSFGKKTVLNNISLDIEEGKCTALIGKNGAGKSTLIDILIGH
KHANSGTVEDKLNLISSHNMGILFQTTNLPKLIKVKELYHLYQQLYTNPM
TFNEFQKLTQFSNLQLEQYANKLSGGQKRLLDFVLTLIGKPQFLILDEPT
TSMDIETREHFWNLIEQLKEDGITILYTSHYIEEVERMADKVVYLEQGSI
KINDTPHNILFSQNNSIIEIMTFTEEQYQILSETYDIEITNGNLKIQTEN
VEAVITNLIKINVDLNQITIYKKSLLELMFSKEERVVQ
>SH2253 
MKGQNPLFFLFKRLSWPYGLIIAAVIISSLGSISGLLIPLFTGRLVDKFS
TSTINWNIVLLFAGIFIANALLSGIGIYLLSKIGEKMIYDIRSILWEHII
KLKMPFFDKNESGQLMSRLTDDTKVINEFISQKLPQLLPAVITLIGSIVM
LFIMDWQMTLLTFIAIPIFMAIMIPLGRKMQKISMNTQTEIANFSGLLGR
VLTEMRLVKVSNTERQELNNAHSNLREIYNLGLRQAKITAVIQPISSVIM
LLMIAVILGFGAIRIATGAITAGALIAMIFYVMQLSMPLMNLSTLVTDYK
KAVGASSRIFEIMQEPIEPMEDLQPIEDISINDGELSFENVDFKYDIKTI
LSNVSFLIPQGEVSAFVGPSGSGKSTIFNLIERMYDIESGDIKYGTQSIY
DVPITNWRNKIGYVMQSNSMMSGTIRDNILYGINREVSDEELVKYAKLAN
CHDFIMQFDDGYDTLVGERGLKLSGGQRQRIDIARSFVKNPDILLLDEAT
ANLDSESEQKIQEALEILMEGRTTIVIAHRLSTIKKAGKIIFLDQGKVTG
EGTHAELMQNHEKYHQFVTTQNLTE
>SH1588 
MTNIITLLDIEYKLLFRRKLSSFMAFIFPLAFYLLFTSLIDMPADAKKVF
YKEYMYSMTVFSLMGFCLMQFPLEIIEERNSGWYKRLISTPITVLNYYLA
KIIKTMTLFLASILLLFCVAHFYKGVDLSVSEWILSGVSLWLGASMFLTL
GLIITQFTETQKASSVANLCNIVLAIIGGLWFPVSTFPDWMQTIAKLTPT
YHLRHLALEFGKGNGFNVQSFIILGIYSIIFLIIALLINKSKEVE
>SH0161 
MFLVWNEIKRNKLKFGLIIGILVLISYLLFLLSGLASGLINMNTEGIKKW
KADAIVLNKDANQTVQQSVFKSSDVEGKFKEEAPLKQIGVIASNGESEEN
ALLFGVTSNSFLIPKIEEGKKFNKDNDVVIDQSLKDKGFKVGDTITLSQS
DEKLHIVGVSESAKYNASPVIFANDKTIEKINPALSSDKTNAVVVKDSNW
KDKNVDKDLEVIGIDDFVENLPGYKPQNLTMNFMITFLFVISATVIGVFL
YVITLQKKNLFGVLKAQGFTNGFLMKMVLAQTFILALIGTLIGLILTLLT
SLVLPEAVPVQFNIGTLIIFGIVLILTSLVGSLFSVLSIRKIDPLKAIG
>SH0151 
MLKIERLTKYIDGKLIFKDISCAINDQHLLISGESGCGKSTLAKIIAGLD
MNYQGDLYFNGQLRKSYTAKEWMKHIQYVPQYQRDTLNQRKTVLSTLLEP
LKNYKFDKQSYTSRIEAVLRQCKLPQSILNQSISTLSGGQFQRVWIAKAL
ILEPEILILDEATINLDVINEEEILQMLIALKQTQLIIITHDAYVLSRFK
GVQLQLEQLNN
>SH1095 
MIRRYLEFVKPYKYRIIATIIIGIIKFGIPMLIPLLIKYAIDGVINNSAL
STNEKFQHLSVAIGIALFIFLIVRPPIEYLRQYLAQWTSNKILYDIRKQL
YNHLQALSARFYANNQVGQVISRVINDVEQTKDFILTGLMNIWLDCITIV
IALSIMFFLDVKLTFAAIFIFPFYILTVYFFFGRLRKLTRKRSQALAEVQ
GFLHERVQGMSVIKSFAIEDNEAKNFDHKNQHFLNRAFQHTSWNAYSFAA
INTVTDLGPIIVIGFGAYLAINGSITVGTLAAFVGYLEQLFGPLRRLVSS
FTTLTQSFASMDRVFQLMDEDYDIKNGIGAQPIEIKQGHIELKNVSFKYN
EDESTILKDINLNINKGDTVAFVGMSGGGKSTLINLIPRFYDVSEGEILI
DDYNVKDFLTGSLRNQIGLVQQDNILFSDTVRENILLGRPDATEEEVIEA
AKMANAHEFIMNLHDGYDTEVGERGVKLSGGQKQRLSIARIFLNNPPILI
LDEATSALDLESEAIIQEALDVLSKDRTTLIVAHRLSTITHADKIIVMQN
GEIVETGTHKELIEKQGAYEHLYSIQNL
>SH0309 
MEHLLQVQDLNKSYKKSNFHLKDISLTLQPGEIIGLIGKNGSGKSTLINT
LVGNRFKDSGEISFFDQVISDKDHAYKEHIGVVFDDLRVPDKLEIKDMDK
VFADIFKTWNSDRFFEVIQRFELPTNVQIKTFSRGMRMKAALAMALAHDT
KLLILDEATAGMDVSGREEVIEMLEDYISEGNGILISSHISEDIEHLATK
LIFMRDGEIVLQESKEELLNQYGIVEVDEHDDLDIPQDIIIASRVRQGQR
QTLVKDWSSVTNANPLNTIDDATKLIMRGDK
>SH2210 bacA, 
MIIIEFIKGLILGIVEGLTEFAPVSSTGHMILVDDMWLKSTEFLGPHSAF
TFKVVIQLGSVFAAAWVFRERYFEMLHIGKYRNSSINEEFRSKPRRLNLL
HVLVGMIPAGILGVLFDDFIEAHLFSVPTVMIGLFLGAIYMIIADKYSKK
VQNPKSVDQINYVQAFVIGISQAVAMWPGFSRSGSTISTGVLMKLDHKSA
SDFTFIMAVPIMLAASALSLVKNYQYIELAHIPFYLIGFLAAFIVGLIAI
KTFLHLINKVKLVPFAIYRIVLVIIIAILYFGFGIGQGISG
>SH1764 blaZ, beta-lactamase
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKE
VKFNSDKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPIL
EKYVGKDITLKALIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGDKV
TNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLD
LMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPI
VLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>SH1532 femA, factor essential for methicillin resistance A(FemA) protein
MKFTNLTATEFGNYTDKMPYSHFTQMTENYEMKVANKTETHLVGIKNKDN
EVIAACMLTAVPVMKFFKYFYSNRGPVIDYDNRELVHFFFNELTKYLKQH
NCLYVRVDPYLPYQYLNHDGEITGNAGNDWFFDKMKHLGFKHEGFTKGFD
PIKQIRYHSVLDLKNKTSKDILNGMDSLRKRNTKKVQKNGVKVKFLSEEE
LPIFRSFMEDTTETKEFQDRDDSFYYNRYRHFKDRVLVPLAYIKFDEYIE
ELQNERETLNKDVNKALKDIEKRPDNKKAFNKKENLEKQLDANQQKLDEA
KKLQAEHGNELPISAGFFFINPFEVVYYAGGTSNKYRHFAGSYAIQWTMI
NYAIDHGIDRYNFYGISGNFSEDAEDVGVIKFKKGFNADVIEYVGDFVKP
INKPLYSVYKTLKKIKKRFN
>SH1531 femB, FemB (factor essential for methicillin resistance B) protein
MKFTELTVKEFENFVQNPSLESHYFQMKENIQTRENDGFEVVLLGVKDES
NKVLAASLFSKIPTMGSYVYYSNRGPVMDYSDLGLVDFYLRELEKYLHQH
QCLYVKIDPYWIYQIYDKDINPLEDREKNDAIVNLFKSHGYEHHGFTTEY
DTSSQARWMGVSYLKGETPASLRKQFDSQRKRNINKAINYGVKVRFLGRD
EFHIFLDLYRETEARTGFVSKTDEYFYNFFDTYGDKVLVPLAYIDLDEYI
KSLQDALNDKENRRDQMMAKENKNDKQLRKIAELDNQIEHDKKELLQASE
LRQTDGQILNLASGIFFANSYEVNYFSGGSSEKYNNYMGPYMMHWHMMNY
CFEHGYDRYNFYGLSGDFTENSEDYGVYRFKRGFNVYIEELIGDFYKPIN
KVKYWLFNTLNTIRKNVKK
>SH0642 fmhA, fmhA protein / lysostaphin immunity factor
MKFVTLSPEEFEKFTSSHFSHYTQSRIHFENRNELKGDVHVVGVKDDSDN
VIAATLMTEARALKVFKYFYTHRGPVMDYSNIELVHFFFKSLTSYLKKHN
CLYVLVDPYILENLRNADGEILESYDNRAVIKTLEDLGYKHQGWTVGYST
MSQIRWLSVLDLKDKSEDQLLKEMDYQTRRNIKKTYEMGVKVRTLPMDET
DTFFELFQMAEEKHGFKFRDKPYFYEMQKTYKDHAMLKLAYIDLKDYLST
LQQKHDSLIEQLAEVDAVLEENPNSKKNKNKRTQIQQQVDSNERKLNETK
NKIAEEGETLNLAAALYLYNEHEVYYLSSGSNPKYNAYMGAYRLQWDMIK
FAKEHNVDRYNFYGITGDFSEDAEDYGVQQFKKGFNANVYEYIGDFIKPI
HPLAYKVKQLLERK
>SH1666 fmhC, FmhC protein
MKFTKLNINEYRSFVEQQFSHYTQSMDLYDYRINRAGGVHIVGVKENGNV
VAACLLTDARIFKVFKYFYTHRGPVMDFTNLALVEFFFKKLTHYVSMRRG
VFILVDPYVLENIRSADGEIIEHFNNKQWFKVMNKLGYQHQGFTTGYSAM
SQIRWHSILDLKDKSEQQLLKDMSYQTRRNIMKTIEMGVQIKTLSIKETN
RFYRLYHMAEEKHGFHFQEEPYFKQMLEIYGDKACMKLAYIDLNKYINLL
KQRAIELEEKVTEIKQSLKVNANSKKTKTKYHQLNQQLESLNKKIAKTEQ
LIITDGTLLDLAAALFIYNNHEMYYLSSGSNPKYNEFMGAYCLQWDMIRY
AKEKGIERYNFYGITGDFGEDAEDYGVQQFKKGFNAFVEEYVGNFIKPVN
KLLYKLYQK
>SH1907 fmt, autolysis and methicillin resistant-related protein
MKNNKLKIIAFILVLIVLILLIILFVIKVTNYSIKDSEYNNVNDNKAYIE
HRDKNHKTVDKLKTVQAKDDNIEQINTYLKNVHFNGSITVLKDGKLMLDK
GYGYQNISSKKKSNANTMYLIGSAQKFTTGLILKHLELSNKININDPVTK
YLPWFKTNKTITLKDLMLHRSGLYKFSANPNTKSLDGAVHDIQRRGINSK
YYHKHLYNDANYLVLAQVIEAVTHHSYVENYYKFLAEPYHLEHSAFFNEK
PYKKNMATGYKVKNEKLKTMKPNTLDQYYGAGNLFMSTHDMARLVNDLQQ
NNIFNQAVTTSLLQEIGSTKYPESYRYGFYSTPQVNRINGVFFGQIFTVY
FNEDYIIVLATNKVDYSKVSNESIISHIYYQLLGQNIYETK
>SH0790 fmtB, FmhB protein, methicillin resistant factor
MEKMNITNQEHDAFVKAHPNGDLLQLTKWAETKRLTGWYSKRVAVGEDGE
IKGVGQLLFKKIPKLPFTLCYVSRGFVTDYSDKAALEQLLEETKKVAKAE
KAYAIKIDPDVEVDKGIDALKNLNALGFKHKGFKEGLSKDYIQPRMTMIT
PIDKSDEEIFQSFERRNRSKVRLSLKRGTKVERSNREGLKNFAELMKITG
ERDGFLTRDLSYFQNIYDSLHEDGDAELFLVKLEPKPVLDDIDNELKELE
SEKTQLQNKYERKQVKKTKNKLNDVEAKIQKSIERKDDMTDLLAKHPNGI
YLSGALLMFAGSKSYYLYGASSNDYRDFLPNHHMQYEMMKFAREHGAKTY
DFGGTDNNPDKDSEHYGLWAFKRVWGTYLSEKIGEFDYVLNQPLYQLIEQ
VKPRLTKAKIKISRKLKGK
>SH0064 hsdM, type I restriction-modification system DNA methylase
MATIGFEEKLWQAADKLRGSMDAAEYKNVALGLIFLKYVSDSFEEKYKEL
KQDPYADEEDQDEYLAENIFWVPKEARWQYINDNAKKPEIGQLIDKAMIA
IEKENESLKGVLPKEYARPALDKEKLGDIIDLFTFKLGDTESRKQDVLGR
VYEYFIAKFASAEGKNAGEFYTPSSIVKLLVEMIEPYKGRIYDPCCGSGG
MFVQSERFVEKHQGRLDDIAIYGQESNPTTWKLAKMNLAIRGIDNDLGER
NADTFHNDLHKGLKADYILANPPFNASDWGQERLLDDYRWQFGVPPKGNA
NYAWIEHMISKLAPNGTAGFVLANGSMSTSGKDELEIRKNLIEQDLVECI
VTLPGQLFYSTQIPVCLWFISNNKGQNGKKERKNEILFIDAREIGHMVSR
TLKEFSDEDIQKVAQTYHSWRGTNDKYYEDIAGFCKVVNLEEVKNNEYIL
TPGRYVGLADVEEDEEPFEQKMKRITSELSEQFAKSKELEDQIRKSLEGL
GYGV
>SH0062 hsdR, type I restriction-modification system restriction subunit
MNFQFNEDDLEQVVLEWLESLSYDYKKGNEISMTGLAPERKSDKDVVLHE
RLEKALRKINSDIHPRFIEKAIHELTLEKSPNLLENNLTFHENLINGIEI
EDYDDEGQSIVEIVKIVDFEHPQNNDFLAVNQFTVVNGDYTKRPDIVLFI
NGLPIVVIELKNSTNETVGVEDGYHQLETYKMRIPQLFTFNEVLVTSDGI
NTKAGSLTANYDRFMTWRSKDGETESSSSLASLDVLINGMLNPKTLLDLI
RYFVLFQDDGKGHISKILAAYHQYYAVNKAVDRALLASSGQGDGKGGVIW
HTQGSGKSLTMVFFSGKLIQMLNNPTLVIVTDRNDLDNQLYSTFVKSKGR
SGKGLLRQTPKQAETRKELKSLLSVESGGIVFTTMQKFEPEQNETIMAAL
TERKNVIVMADEAHRTQYGFNAKYDDKGEGIKYGYAKYLRDALPNATFVG
FTGTPVASTDKNTQMVFGNYIDVYDMTQAVADGSTVKIYYESRVIPLNLP
QSLDLDEAYNDITEDQEEDVKQRLKSKWSRIEALAGAKPRVEALAKDIIQ
HFETRQQAMKGKGMIVTMSRRIAVDLYDEIIRLKPEWHSDDDDKGVIKVV
MTGSSSDPTSFQRHIGPKKRRSVLEKRMKDVNDELQLVIVRDMWLTGFDV
PSMHTMYIDKPMKGHNLMQAIARVNRVFKDKPGGLIVDYVGIAESLKEAL
KEYTESDQAQTAIDTDKAVELMLLKYDVIQDMLYNLDYSKFNSEKKSERY
YTISNTMDYVIGLGEDERQRFIKTVTELGKAFALCATEPTAQELNDEIAF
FKAVKAGLVKLLQPPKEGKTRKTPAEVEAEINQLVSQSVVTEDVIDVYQT
LGLEQPDLSILSDDFLKDVEGLKQKNVAVELLNRLLKGQVKSLMKTNATV
SKRFSEMLGNSINKYNSRSIETSKVIEELIQLAKDIKQEQQRGNELGLNS
DEIAFYDALVSHETAKKAMEDKKLRAIAHELTKTVKENMSVDWSKRDSAK
AKMRVAVRRLLKKYGYPPDLQKMAVEQVVEQAELMASNQ
>SH0063 hsdS, 
MEYKLEKLLDSVSIKHPFSKKNVVFLNTSDIEEGNILKKEYSKIDDLPGQ
AKKSIQPNDILYSEIRPKNKRYAYINFECDDYVVSTKLMVLRNINPDLVH
SKYLYYFLIDQKTVNYLQNIAESRSGTFPQITFSEVKNLKLDLPSIEKQI
TIINIMDTLNEKINNNKKIISNLEELSQTSFKRWFVDFEFPDEDGNPYKS
SGGEMIDSELGEIPKNWSIKTVKEIAESFNSIRKPLSKIEREKRESIYPY
YGATKIIDYVDNYIFDGKYILVGEDGTVQTETGNPFIQYVWGKFWVSNHA
HILKGKLISDELLMLYLKNTNVAPYITGAVQPKLNKKNLNSIKFVIADKE
TIIKFENSIKSYFQKIRILNKENKKLIELRDTLLPKLMSGEIEIPDDIEV
NIDELSI
>SH2664 vraD, ABC transporter ATP-binding protein VraD
MPILNVNHLSKVYGSKQKYKALHDINFSVDKGEFVAIMGPSGSGKTTLLN
VISSIDSISGGTVEVSGNEINQLKDKQLAQFRKKELGFIFQDYSVLPTLT
VKENIMLPLSVQKVSKDEMEQNYKEVTEALGIYELSDKYPSEISGGQQQR
TAAARAFVHKPAIIFADEPTGALDSKSAQDLLNRLEDMNERFNSTIIMVT
HDPSAASFAQRVIMLKDGNIHSEIHQEDKSKREFYNEIIQLQSALGGVAN
DV
>SH2665 vraE, ABC transporter permease protein VraE
MTFNQITLKNLKSNFKNYALYLFSLIFSIILYFSFVTLQYTHSINNGGSP
KVIQEGAKVGSVFLFITIIIFLMYANQLFIKRRTREFALFQLIGLTRQNI
LRMLAIEQLTFFFITGIIGILIGIVGSEILLNILVKMMHLKVGVSIGFEF
PALIQTIVMLVLAFILIMFQNFLFLKRRTILSMMKDSTKSEATKAKITVP
ELIAGILGIIMIIFGYYISTEMFGKFEVLTMVLVTPFLILFLTVVGAYLF
FRSSVSIIFKSLKKSKHGRISITDVVFTSSIMHRMKKNAMSLTIIAVISA
VTVTILCFGAISKANTDYMIQVSSPQDVNFSKTESAQKYEKLLKQNHIQY
DTKTFEGSNTKLFKNDALKSKTNEGMQNTGIVVMPDKNNKGNHATITNLQ
GPLSGIVSVHTNKDMTLQGQQKMTLNVNKKDDNEVIPSTVSIGGPVLKVS
PDNFNKLKMKDQLMHHYGFNIKDHKDLSKAETLAQKVSPNVELKNDTKKM
LDESNGILIFVTSFLGLAFLIAAGCIIYIKQMDETEDEINNYRILRRIGF
THTDMTKGLALKILFNFGLPLIIALLHALFAAMVFMKLMGEYSPIPIIIV
MIVYSLVYLIFAAISFIHANRIVKHSI
>SH2233 vraF, putative ABC-type transport system, ATPase component
MAILQAKQIAKTYGNKQTEQEVLKDIDLSIEAGEFVAIMGPSGSGKTTLL
NVLSSIDYLTHGSIILDGQQLEKLSNKALSEIRKKDIGFIFQEYNLLHTL
TVKENIMLPLSVQKLDKKEMNERYQRITQALNIFEISDKYPSDISGGQRQ
RTSAARAFITYPKIIFADEPTGALDSKNTRDLLQRFQKINELYNATIVMV
THDPLAASFSERVIMLKDGQVFTEIYQGEDDKNVFHKEILRAQSILGGMM
YEF
>SH2232 vraG, putative ABC-type transport system, permease component
MSFSQIIWKNFQQNIIHYAIYIFSLVLSIVLFFSFITIKYVHHLNVHQSL
SMIQQGTQVGSYFLFIIIVVFIMYTNMLFIKRRSYEFGLLQTIGLGKKSI
IYMLMLEQLFIFIITALLGMIIGILGSKILLMIVLKLLGIHTSVSITFSF
QAIAQTFFILVIAYILIIIQASIYLSKSSIKSLMASQDSKEDSHITLTLG
EVILGVLGIVLILTGYYLSTRFVEIVDDVILPFVILILTVLGTYFFFRST
ISLILKTIRYLKGGNVSVNDVIFTSSLMFRIRKNAFSLTVMAIISAITVS
VLCFAAISRGSLTNEILLESPHEVTLKEEKVANELGFELNRHHIPYHYDF
KQVVYSQLYKDHLFDKNQVQPYAITVTSEKYFPNVSIEKGEANLIMPEGL
IHDLSKHTPHGTASIGTKKHHVNIKLNKVMDKIYFKQSIDLGGPTLVLND
TDYNYLKAHAKNKYIVSQYAFDLKHNRDIPKLESITKDLDGNVQTRSEVV
SEVSSLTGILLFVTSFLGIAFLIATGCIIYIKQIDETEDELESYSVLRKL
GFIQKDMAKGLKLKVAFNFSIPLIIALLHSYFAAVVFMKVIGFDNKVPIF
VVMGIYTIIYSIFAVIAYNHSKRTINHSI